| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8683515 | Epilepsy & Behavior | 2018 | 7 Pages |
Abstract
The current data support the value of adjunctive PER in child and adolescent patients with pharmacoresistant epilepsy in daily clinical practice. Perampanel was efficacious and generally well-tolerated as an add-on treatment for epilepsy.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Kuang-Lin Lin, Jainn-Jim Lin, Ming-Liang Chou, Po-Cheng Hung, Meng-Ying Hsieh, I-Jun Chou, Siew-Na Lim, Tony Wu, Huei-Shyong Wang,